Active Lungs & Breathing NIHR-supported project Pregnancy, Children & Inherited Conditions

CoReCCT: The Awake Prone Study: Awake prone positioning in patients with acute hypoxaemic respiratory failure not due to COVID-19: A randomised controlled trial

In plain English

AI plain-English summary

Turning a patient with severe breathing failure onto their stomach while they are still awake could reduce the need for a breathing tube and a ventilator. This trial is part of a larger effort called CoReCCT, which bundles multiple critical care studies together to cut through the administrative red tape that often slows down research in intensive care units. The problem is straightforward: acute respiratory failure kills or injures many patients, and the best way to position them before they need a ventilator is not settled. If the awake prone positioning works, it could spare patients the risks of sedation, muscle paralysis, and ventilator-associated lung injury. The trial also tests better ways to insert breathing tubes and to wean patients off ventilators afterward. Success would mean fewer days in intensive care, lower costs for the NHS, and a simpler, more reliable playbook for frontline doctors. The project does not promise a cure, but it systematically tests four practical interventions along the patient’s entire care pathway, from the ward to the ventilator and back.

View original technical description
CoReCCT (the Confederation of Respiratory Critical Care Trials) has been established as a novel concept to group a range of respiratory critical care trials, with an overarching aim to streamline trial delivery across areas such as governance, contracting, and data collection. The overriding objective is to improve deliverability by minimising burden on participating sites and participants. The primary aim of the clinical trials (domains) within CoReCCT is to test the clinical and cost effectiveness of four interventional strategies on the patient outcomes in hospitalised adults with moderate to severe acute respiratory failure that may require tracheal intubation and mechanical ventilation support. The interventional strategies are presented as a series of clinical trials (domains), which occur both sequentially and concurrently along the clinical care pathway of a patient with moderate to severe acute respiratory failure. These domains include the Awake Prone Study (pre-intubation), PROTECT Airways trial (intubation), RELEASE trial and NAVA trial (both post-intubation).

Researchers

Michael Steiner (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

PROTECT-airways
Awake prone positioning in patients with acute hypoxaemic respiratory failure not due to COVID-19: a multi-centre, pragmatic, allocation concealed, individual patient randomised, parallel group, open-label clinical trial (AWAKE-PRONE)
RELEASE: CoReCCT: Airway Pressure Release Ventilation (APRV) vs conventional ventilation for patients with moderate to severe acute hypoxemic respiratory failure
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)
Randomized, Embedded, Multifactorial, Adaptive Platform trial for Community-Acquired Pneumonia

Original classification

Respiratory

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.